APA (7th ed.) Citation

Adam, J., Cleary, M., Hendriksz, C., Geberhiwot, T., Hughes, D., Jones, S. A., . . . Vijay, S. (2019). Impact of two-year elosulfase alfa treatment on patient-reported outcomes in patients with Morquio syndrome type A: Results from an English managed access agreement. Molecular Genetics & Metabolism, 126(2), S19. https://doi.org/10.1016/j.ymgme.2018.12.022

Chicago Style (17th ed.) Citation

Adam, Jacqueline, et al. "Impact of Two-year Elosulfase Alfa Treatment on Patient-reported Outcomes in Patients with Morquio Syndrome Type A: Results from an English Managed Access Agreement." Molecular Genetics & Metabolism 126, no. 2 (2019): S19. https://doi.org/10.1016/j.ymgme.2018.12.022.

MLA (9th ed.) Citation

Adam, Jacqueline, et al. "Impact of Two-year Elosulfase Alfa Treatment on Patient-reported Outcomes in Patients with Morquio Syndrome Type A: Results from an English Managed Access Agreement." Molecular Genetics & Metabolism, vol. 126, no. 2, 2019, p. S19, https://doi.org/10.1016/j.ymgme.2018.12.022.